Proglucagon-derived peptides: Mechanisms of action and therapeutic potential

被引:72
作者
Sinclair, EM [1 ]
Drucker, DJ
机构
[1] Toronto Gen Hosp, Dept Med, Banting & Best Diabet Ctr, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
关键词
D O I
10.1152/physiol.00030.2005
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic actions of the proglucagon-derived peptides, with an emphasis on clinical relevance of the pepticles for the treatment of human disease.
引用
收藏
页码:357 / 365
页数:9
相关论文
共 131 条
  • [41] GLUCAGONLIKE PEPTIDE-I STIMULATES INSULIN GENE-EXPRESSION AND INCREASES CYCLIC-AMP LEVELS IN A RAT ISLET CELL-LINE
    DRUCKER, DJ
    PHILIPPE, J
    MOJSOV, S
    CHICK, WL
    HABENER, JF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) : 3434 - 3438
  • [42] Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
    Drucker, DJ
    Shi, Q
    Crivici, A
    SumnerSmith, M
    Tavares, W
    Hill, M
    DeForest, L
    Cooper, S
    Brubaker, PL
    [J]. NATURE BIOTECHNOLOGY, 1997, 15 (07) : 673 - 677
  • [43] Induction of intestinal epithelial proliferation by glucagon-like peptide 2
    Drucker, DJ
    Ehrlich, P
    Asa, SL
    Brubaker, PL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7911 - 7916
  • [44] Nutrient, neural and endocrine control of glucagonlike peptide secretion
    Dubé, PE
    Brubaker, PL
    [J]. HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 755 - 760
  • [45] Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression
    Dunphy, JL
    Taylor, RG
    Fuller, PJ
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 141 (1-2) : 179 - 186
  • [46] Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
    During, MJ
    Cao, L
    Zuzga, DS
    Francis, JS
    Fitzsimons, HL
    Jiao, XY
    Bland, RJ
    Klugmann, M
    Banks, WA
    Drucker, DJ
    Haile, CN
    [J]. NATURE MEDICINE, 2003, 9 (09) : 1173 - 1179
  • [47] Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans - Studies with the antagonist exendin 9-39
    Edwards, CMB
    Todd, JF
    Mahmoudi, M
    Wang, ZL
    Wang, RM
    Ghatei, MA
    Bloom, SR
    [J]. DIABETES, 1999, 48 (01) : 86 - 93
  • [48] GLUCAGON-LIKE PEPTIDE-1(7-36)AMIDE AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE SECRETION IN RESPONSE TO NUTRIENT INGESTION IN MAN - ACUTE POSTPRANDIAL AND 24-H SECRETION PATTERNS
    ELLIOTT, RM
    MORGAN, LM
    TREDGER, JA
    DEACON, S
    WRIGHT, J
    MARKS, V
    [J]. JOURNAL OF ENDOCRINOLOGY, 1993, 138 (01) : 159 - 166
  • [49] ENG J, 1992, J BIOL CHEM, V267, P7402
  • [50] Tales beyond the crypt: Glucagon-like peptide-2 and cytoprotection in the intestinal mucosa
    Estall, JL
    Drucker, DJ
    [J]. ENDOCRINOLOGY, 2005, 146 (01) : 19 - 21